Year Founded
2005
Ownership
Private
Employees
~10
Stage
Commercial
Modalities
Small molecule

Global Pharma Advisory General Information

Company faced significant FDA warning letter due to contaminated ophthalmic products that led to serious adverse events including vision loss and deaths. Multiple product recalls were initiated in 2023.

Contact Information

Website
Primary Industry
[ "Consulting" ]
Corporate Office
Thiruporur, Tamil Nadu
India

Drug Pipeline

Artificial Tears
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Global Pharma Advisory's pipeline data

Book a demo

Key Partnerships

EzriCare LLC, Delsam Pharma LLC

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Global Pharma Advisory Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Global Pharma Advisory's complete valuation and funding history, request access »